Table 2
Treatments, outcomes, and follow-up
Patient # Preoperative
imaging
Primary
operation
Definitive
operation
IRS
Group
Operations
for metastases
Chemo- or
biologic
therapy
Radiation
to primary
Radiation to
metastases
Follow-up since
diagnosis (mo)
Progression-free
survival (mo)
Status
1
Y
Excisional biopsy WLE/LNBx
I
2
(+)
1500 cGy to lungs
135
13
NED
2
?
Incisional biopsy
WLE/LND
I
3
(+)
Brachytherapy
I-192
4500 cGy
148
7
NED
3
Y
Excision,
(+) margins
WLE/SNBx
I
1
22
18
AWD
4
?
Incisional biopsy
IV
(+)
16
16
AWD
5
?
Excisional biopsy WLE/LNBx
I
(+)
290
284
AWD
6
N
Excisional biopsy WLE/LND
I
11
11
NED
7
N
Unknown
Unknown 4
(+)
XRT
XRT to acetabulum 207
21
DOD
8
N
Excision,
(+) margins
WLE/LNBx
I
6
6
NED
9
N
Excisional biopsy WLE
(mastectomy)
I
175
175
NED
10
N
Excisional biopsy
IV
8
(+)
239
8
NED
11
Y
Excisional biopsy
IV
1
(+)
21
21
AWD
12
N
Excision,
(+) margins
WLE/LND
IIb
5580 cGy XRT
15
15
NED
13
N
Excision,
(+) margins
WLE
I
4
4
NED
14
Y
Embolization,
core biopsy
WLE/SNBx
I
10
10
NED
15
Y
Core biopsy
WLE
IV
2
50
44
AWD
16
N
Excisional biopsy WLE
I
51
51
NED
17
?
Incisional biopsy
IV
(+)
XRT
16
10
DOD
18
?
Unknown
Unknown 5
(+)
4000 cGy XRT 50 Gy pelvic XRT;
129 mCi I-125
implants; Ir-192
implants
354
8
AWD
19
Y
Incisional biopsy
WLE/
intramedullary
rod
IV
5
(+)
XRT
59
12
DOD
20
Y
Incisional biopsy
IV
(+)
3000 cGy
whole brain
6
1
AWD
WLE, wide local excision; LND, lymph node dissection; LNBx, excisional lymph node biopsy; SNBx, sentinel node biopsy; XRT, external-beam radiation therapy; NED, no evidence of disease; AWD, alive
with disease; DOD, dead of disease.
M.L.
Kayt
on
et
al.
190
